Related Experiment Video

Updated: Jul 14, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Current United Kingdom sedation practice in pediatric intensive care

Ian A Jenkins1, Stephen D Playfor, Cliff Bevan

  • 1Paediatric Intensive Care Society Study Group, UK. ian.jenkins@ubht.nhs.uk

Paediatric Anaesthesia
|June 15, 2007
PubMed

Insights

Pediatric intensive care units (PICUs) show varied sedation and analgesia practices. Neuromuscular blockers (NMBs) are common, and withdrawal symptoms occur frequently, unaffected by gradual sedative weaning.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology
  • Clinical Practice Research

Background:

  • Critically ill children in UK Pediatric Intensive Care Units (PICUs) require sedation, analgesia, and neuromuscular blockade.
  • Understanding current practices is crucial for improving patient care and identifying research gaps.

Purpose of the Study:

  • To investigate current sedation, analgesia, and neuromuscular blockade practices in UK PICUs.
  • To identify areas for further research in pediatric critical care.

Main Methods:

  • Prospective observational study involving 338 critically ill children across 20 UK PICUs.
  • Data collection on sedative, analgesic, and neuromuscular blocking agent usage.

Main Results:

  • Significant variation in the use of 24 different sedative and analgesic agents, with midazolam and morphine being most common.
  • Neuromuscular blockers (NMBs) used in 30% of ventilated patients; vecuronium most frequent.
  • Withdrawal symptoms reported in 13% of ventilated patients; gradual sedative weaning ('tapering') showed no benefit. Clonidine use and physical restraints also noted.

Conclusions:

  • Heterogeneity in sedation techniques is evident in UK PICUs.
  • NMBs are frequently employed in critically ill children.
  • Withdrawal symptoms are linked to higher sedation doses and longer hospital stays, and are not prevented by gradual sedative tapering.
Abstract

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...